We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+9.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.6B
AUM Growth
+$2.6B
(+22%)
Cap. Flow
+$859M
Cap. Flow
% of AUM
5.88%
Top 10 Holdings %
Top 10 Hldgs %
21.92%
Holding
958
New
131
Increased
364
Reduced
334
Closed
74
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$135M |
| 2 |
Royal Bank of Canada
RY
|
+$120M |
| 3 |
Agilent Technologies
A
|
+$72.5M |
| 4 |
UnitedHealth
UNH
|
+$71.5M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$64.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$90.3M |
| 2 |
Amgen
AMGN
|
+$88.7M |
| 3 |
Allstate
ALL
|
+$52.2M |
| 4 |
Union Pacific
UNP
|
+$47.1M |
| 5 |
Bio-Rad Laboratories Class A
BIO
|
+$44.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.42% |
| 2 | Technology | 23.2% |
| 3 | Consumer Discretionary | 9.14% |
| 4 | Financials | 8.63% |
| 5 | Communication Services | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Arista Networks
ANET
$215B
| $1.13M | 0.01% |
50,048
-86,560
| -63% | -$1.81M |
|
677
Lincoln National
LNC
$7.88B
| $1.13M | 0.01% |
17,900
-3,768
| -17% | -$249K |
|
678
Insulet
PODD
$11.4B
| $1.12M | 0.01% |
4,092
+594
| +17% | +$161K |
|
679
Teradyne
TER
$52.4B
| $1.12M | 0.01% |
+8,386
| New | +$1.07M |
|
680
Burlington
BURL
$22.5B
| $1.12M | 0.01% |
3,483
-91
| -3% | -$29K |
|
681
HEICO Corp Class A
HEI.A
$36.3B
| $1.12M | 0.01% |
9,030
+1,453
| +19% | +$184K |
|
682
Caesars Entertainment
CZR
$6.1B
| $1.12M | 0.01% |
+10,795
| New | +$1.09M |
|
683
Workiva
WK
$3.13B
| $1.11M | 0.01% |
10,000
+1,030
| +11% | +$100K |
|
684
Corpay
CPAY
$24.8B
| $1.1M | 0.01% |
4,302
-304
| -7% | -$84.1K |
|
685
Corteva
CTVA
$58.6B
| $1.09M | 0.01% |
24,638
-15,769
| -39% | -$729K |
|
686
CarMax
KMX
$8.29B
| $1.09M | 0.01% |
8,434
-381
| -4% | -$47.1K |
|
687
Standard BioTools
LAB
$303M
| $1.07M | 0.01% |
173,646
-144,685
| -45% | -$773K |
|
688
Bath & Body Works
BBWI
$4.13B
| $1.07M | 0.01% |
+18,324
| New | +$990K |
|
689
Sun Life Financial
SLF
$46B
| $1.06M | 0.01% |
20,532
-223,669
| -92% | -$11.8M |
|
690
NetApp
NTAP
$33.3B
| $1.05M | 0.01% |
12,887
-66,031
| -84% | -$5.16M |
|
691
Teleflex
TFX
$5.8B
| $1.04M | 0.01% |
2,596
+304
| +13% | +$125K |
|
692
Las Vegas Sands
LVS
$31.6B
| $1.04M | 0.01% |
19,766
-812
| -4% | -$46.9K |
|
|
WRK
693
DELISTED
WestRock Company
WRK
| $1.04M | 0.01% |
19,549
-35,643
| -65% | -$1.99M |
|
694
Dentsply Sirona
XRAY
$2.61B
| $1.03M | 0.01% |
16,212
-3,981
| -20% | -$262K |
|
695
MGM Resorts International
MGM
$11.8B
| $1.02M | 0.01% |
24,030
-20,399
| -46% | -$844K |
|
696
Annaly Capital Management
NLY
$16.9B
| $1.01M | 0.01% |
28,426
+432
| +2% | +$15.7K |
|
697
MarketAxess Holdings
MKTX
$4.19B
| $1.01M | 0.01% |
+2,176
| New | +$1.04M |
|
698
SiriusXM
SIRI
$10.5B
| $1M | 0.01% |
3,300
+2,275
| +222% | +$143K |
|
699
Fox Class B
FOX
$21.3B
| $1M | 0.01% |
28,435
-6,821
| -19% | -$247K |
|
700
Sun Communities
SUI
$15B
| $995K | 0.01% |
5,808
| – | – |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2021 Portfolio in Review
As of Q2 2021, Candriam SCA held 958 positions worth $14.6B, up 22% from $12B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Candriam SCA deployed $859M of net new capital in Q2 2021, opening 131 new positions and adding to 364 existing holdings. Its largest new stake was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $90.3M trimmed.
- Candriam SCA's largest Q2 2021 buy was SailPoint Technologies Holdings, Inc. Common Stock: 738,233 shares worth $37.7M.
- Candriam SCA added most to Microsoft in Q2 2021, an estimated $135M increase.
- Candriam SCA's biggest Q2 2021 reduction was Bristol-Myers Squibb, cutting an estimated $90.3M.
- Candriam SCA fully exited Tenable Holdings in Q2 2021, selling an estimated $31.6M.
- Candriam SCA's ten largest holdings make up 22% of its $14.6B portfolio in Q2 2021.
- Candriam SCA opened 131 new positions and closed 74 in Q2 2021.
- Candriam SCA's portfolio value rose 22% quarter-over-quarter to $14.6B.
Based on Candriam SCA's 13F filing for Q2 2021, filed 20 Jul 2021.